Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Indoles
  • Kidney Neoplasms
  • Pyrroles

abstract

  • These analyses identified risk factors to survival with sunitinib, including potential ethnic-based differences, and validated risk factors previously reported in advanced RCC.

publication date

  • June 25, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3694236

Digital Object Identifier (DOI)

  • 10.1038/bjc.2013.236

PubMed ID

  • 23695024

Additional Document Info

start page

  • 2470

end page

  • 7

volume

  • 108

number

  • 12